The global sickle cell anemia testing and screening market size was evaluated at USD 479.09 million in 2024 and is expected to grow around USD 13,50.07 million by 2034, registering a CAGR of 12.2% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 479.09 Million |
| Market Size by 2034 | USD 13,50.07 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 12.2% |
Sickle cell anemia testing is the process of identifying the presence of abnormal hemoglobin (HbS) through blood tests and genetic tests on individuals. This test can confirm whether the individual has sickle cell disease or other traits. Screening for sickle cell anemia involves testing the blood of an individual with a complete blood count to detect abnormal hemoglobin.
The sickle cell anemia testing and screening market is rapidly growing due to the rise in the number of patients with sickle cell disease. An increase in the awareness for such testing & screening with investment by the government in the healthcare sector and biotech boosts market growth.
“Protein Plus BCT is an excellent addition to the Streck stabilization line. We are excited to enter the rapidly growing field of proteomics and are enthusiastic to provide a tool that not only improves laboratory efficiency but also gives customers confidence in the accuracy of their results.”
"As the number of cell and gene therapies entering the market increases, we see a growing emphasis on the need for products to ensure safety and efficacy across production processes. We believe that Droplet Digital PCR solutions can help address this unmet need. The introduction of Bio-Rad’s newest Vericheck ddPCR kits for RCL and RCAAV to our growing portfolio reflects our ongoing commitment to providing innovative QC tools to support advances in the cell and gene therapy space."
North America
North America dominated the sickle cell anemia testing and screening market in 2024. The presence of leading global laboratories and government support with incentives and investment for the healthcare infrastructure boosts the market growth. Furthermore, the government has also introduced newborn screening programs for early detection and treatment of sickle cell disease. Moreover, an increase in awareness campaigns and investments from the private sector contribute to the sickle cell anemia testing and screening market.
Europe
Europe is predicted to be the fastest-growing region for the sickle cell anemia testing and screening market in the forecasted period of 2025-2034. This was due to the increase in awareness and government support in healthcare and advanced diagnostics and research facilities. Many countries in Europe have now introduced and increased newborn screening for sickle cell disease, and a few of them have integrated this into routine neonatal care, ensuring early detection and treatment.
The sickle cell anemia testing and screening market is highly competitive, with leading companies all over the globe. Companies that hold the largest market share are Streck, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America Holdings, Request A Test, Ltd, Halcyon Biomedical Incorporated, Silver Lake Research Corporation, and Bio-Rad Laboratories, Inc.
The market is dominated by several companies, but the companies that are renowned for their contribution to the market are listed below:
Labcorp Holding Inc. is a leading global company providing laboratory services for healthcare and diagnosis. It is one of the largest clinical laboratory networks, with operations throughout the world in 100 different countries.
Bio-Rad Laboratories, Inc. is a leading global manufacturer of specialized technological products for the research and clinical diagnostics market. The company’s products include content for drug discovery, gene expression, cell biology, protein purification, and many more.
Streck, Inc. is a leading global developer and manufacturer of laboratory products used in research and development for clinical and laboratories. The company has a significant presence in the market for the production of quality control products used in laboratories.
Published by Kesiya Chacko
